Compare · AZZ vs ZBH
AZZ vs ZBH
Side-by-side comparison of AZZ Inc. (AZZ) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- AZZ operates in Industrials, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $17.63B, about 4.0x AZZ ($4.42B).
- Over the past year, AZZ is up 31.8% and ZBH is down 2.2% - AZZ leads by 34.0 points.
- AZZ has been more active in the news (17 items in the past 4 weeks vs 11 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 14 for AZZ).
- Company
- AZZ Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $147.10-2.59%
- $91.13-2.79%
- Market cap
- $4.42B
- $17.63B
- 1M return
- -4.08%
- +2.00%
- 1Y return
- +31.83%
- -2.18%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 17
- 11
- Recent ratings
- 14
- 25
AZZ Inc.
AZZ Inc. provides galvanizing and metal coating solutions, welding solutions, specialty electrical equipment, and engineered services to the power generation, transmission, distribution, refining, and industrial markets in the United States and internationally. The company operates through two segments, Infrastructure Solutions and Metal Coatings. The Metal Coatings segment offers hot dip galvanizing, powder coating, anodizing, plating, and other metal coating applications to the steel fabrication and other industries. It serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical, and general industrial markets, as well as original equipment manufacturers. The Infrastructure Solutions segment provides products and services to support industrial and electrical applications. It offers custom switchgear, electrical enclosures, medium and high voltage bus ducts, explosion proof and hazardous duty lighting, nuclear safety-related equipment, and tubular products, as well as solutions and engineering resources to multi-national companies and small independent companies. This segment sells its products through internal sales force, manufacturers' representatives, distributors, and agents. The company was incorporated in 1956 and is headquartered in Fort Worth, Texas.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest AZZ
- AZZ Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by AZZ Inc.
- AZZ Inc. Reports Fiscal Year 2027 First Quarter Results
- Director Berce Daniel E was granted 937 shares, increasing direct ownership by 2% to 59,290 units (SEC Form 4)
- Director Mcgough Ed was granted 937 shares, increasing direct ownership by 5% to 20,306 units (SEC Form 4)
- Director Grannum Clive A was granted 937 shares, increasing direct ownership by 9% to 11,145 units (SEC Form 4)
- Director Purvis Steven R. was granted 937 shares, increasing direct ownership by 4% to 23,862 units (SEC Form 4)
- Director Schapper Aaron M was granted 937 shares (SEC Form 4)
- Director Treadway Charles L. was granted 937 shares (SEC Form 4)
- Director Jackson Carol R was granted 937 shares, increasing direct ownership by 9% to 11,145 units (SEC Form 4)
Latest ZBH
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
- Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
- BMO Capital Markets initiated coverage on Zimmer Biomet with a new price target
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Kurdikar Devdatt
- SEC Form 4 filed by Director Hagemann Robert
- SEC Form 4 filed by Director Higgins Arthur J
- SEC Form 4 filed by Director Kolli Sreelakshmi
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Shapiro Louis